Literature DB >> 12110308

Molecular docking and 3-D-QSAR studies on the possible antimalarial mechanism of artemisinin analogues.

Feng Cheng1, Jianhua Shen, Xiaomin Luo, Weiliang Zhu, Jiande Gu, Ruyun Ji, Hualiang Jiang, Kaixian Chen.   

Abstract

Artemisinin (Qinghaosu) is a natural constituent found in Artemisia annua L, which is an effective drug against chloroquine-resistant Plasmodium falciparum strains and cerebral malaria. The antimalarial activities of artemisinin and its analogues appear to be mediated by the interactions of the drugs with hemin. In order to understand the antimalarial mechanism and the relationship between the physicochemical properties and the antimalarial activities of artemisinin analogues, we performed molecular docking simulations to probe the interactions of these analogues with hemin, and then performed three-dimensional quantitative structure-activity relationship (3-D-QSAR) studies on the basis of the docking models employing comparative molecular force fields analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA). Molecular docking simulations generated probable 'bioactive' conformations of artemisinin analogues and provided a new insight into the antimalarial mechanism. The subsequent partial least squares (PLS) analysis indicates that the calculate binding energies correlate well with the experimental activity values. The CoMFA and CoMSIA models based on the bioactive conformations proved to have good predictive ability and in turn match well with the docking result, which further testified the reliability of the docking model. Combining these results, that is molecular docking and 3-D-QSAR, together, the binding model and activity of new synthesized artemisinin derivatives were well explained.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12110308     DOI: 10.1016/s0968-0896(02)00161-x

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  10 in total

1.  Structure-based prediction of free energy changes of binding of PTP1B inhibitors.

Authors:  Jing Wang; Shek Ling Chan; Kal Ramnarayan
Journal:  J Comput Aided Mol Des       Date:  2003-08       Impact factor: 3.686

2.  Clinical pharmacokinetics of the diastereomers of arteether in healthy volunteers.

Authors:  Sreedharan N Sabarinath; Omkar P Asthana; Sunil K Puri; Kumkum Srivastava; Kunnath P Madhusudanan; Ram C Gupta
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

3.  Modeling of peroxide activation in artemisinin derivatives by serial docking.

Authors:  Roy J Little; Alexis A Pestano; Zaida Parra
Journal:  J Mol Model       Date:  2009-01-14       Impact factor: 1.810

4.  Characterization of noncovalent complexes of antimalarial agents of the artemisinin-type and FE(III)-heme by electrospray mass spectrometry and collisional activation tandem mass spectrometry.

Authors:  Vlada A Pashynska; Hilde Van den Heuvel; Magda Claeys; Marina V Kosevich
Journal:  J Am Soc Mass Spectrom       Date:  2004-08       Impact factor: 3.109

5.  A study on antimalarial artemisinin derivatives using MEP maps and multivariate QSAR.

Authors:  Fábio José B Cardoso; Antonio Florêncio de Figueiredo; Maycon da Silva Lobato; Ricardo Moraes de Miranda; Ruth Catarine O de Almeida; José Ciríaco Pinheiro
Journal:  J Mol Model       Date:  2007-10-30       Impact factor: 1.810

Review 6.  Qinghaosu (artemisinin): chemistry and pharmacology.

Authors:  Ying Li
Journal:  Acta Pharmacol Sin       Date:  2012-08-27       Impact factor: 6.150

7.  Computational Analysis of Artimisinin Derivatives on the Antitumor Activities.

Authors:  Hui Liu; Xingyong Liu; Li Zhang
Journal:  Nat Prod Bioprospect       Date:  2017-11-01

Review 8.  Biological actions of artemisinin: insights from medicinal chemistry studies.

Authors:  Jian Li; Bing Zhou
Journal:  Molecules       Date:  2010-03-08       Impact factor: 4.411

9.  Molecular modeling and evaluation of binding mode and affinity of artemisinin-quinine hybrid and its congeners with Fe-protoporphyrin-IX as a putative receptor.

Authors:  Rajani Kanta Mahapatra; Niranjan Behera; Pradeep Kumar Naik
Journal:  Bioinformation       Date:  2012-04-30

10.  Pharmacokinetic study and bioavailability of a novel synthetic trioxane antimalarial compound 97/63 in rats.

Authors:  Hari Narayan Kushwaha; Neel Kamal Mohan; Ashok Kumar Sharma; Shio Kumar Singh
Journal:  Malar Res Treat       Date:  2014-09-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.